Announce Date | 05/01/2025 |
EPS Normalized Actual | $1.12 (Beat by $0.06) |
EPS GAAP Actual | $1.12 (Beat by $0.06) |
Revenue Actual | $1.9B |
Revenue Surprise | Beat by $1900M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.93418 |
EPS GAAP Estimate | $0.93418 |
Revenue Estimate | $1.810369533B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 4.8 | 43.71 | 4.73617 | 4.89537 | 1 |
Dec 2025 | 4.21 | 49.83 | 3.87 | 4.65 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.96 | -0.17758 | 1.9B | 1.23% | -112.94M |
FQ4 2024 (Dec 2024) | 1.38 | 0.36315 | 1.909B | 2.3% | -22.59M |
FQ3 2024 (Sep 2024) | 0.67 | 0.67 | 1.73787B | 8.28% | 1737.87M |
FQ2 2024 (Jun 2024) | 1.87 | 1.87 | 1.73964B | 5.33% | 1739.64M |
FQ1 2024 (Mar 2024) | 1.06 | 1.06 | 1.87658B | 7.38% | 1876.58M |
FQ4 2023 (Dec 2023) | 1.53 | 1.53 | 1.86516B | 5.37% | 1865.16M |
FQ3 2023 (Sep 2023) | 0.8 | 0.8 | 1.594B | 1.25% | 1594M |
FQ2 2023 (Jun 2023) | 1.9 | 1.9 | 1.647B | 2% | 1647M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0.93418
Consensus Revenue Estimates
1.810369533B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.24424 | -- | 1.23334 | 1.27632 | 2 |
FQ3 2027 (Sep 2027) | 1.0912 | -- | 1.08164 | 1.11933 | 2 |
FQ2 2027 (Jun 2027) | 1.10486 | -- | 1.09518 | 1.13334 | 2 |
FQ1 2027 (Mar 2027) | 1.20521 | -- | 1.19466 | 1.23628 | 2 |
FQ4 2026 (Dec 2026) | 1.22897 | -- | 1.21939 | 1.24033 | 4 |
FQ3 2026 (Sep 2026) | 0.97988 | -- | 0.96819 | 0.99993 | 3 |
FQ2 2026 (Jun 2026) | 0.99864 | -- | 0.98673 | 1.01908 | 3 |
FQ1 2026 (Mar 2026) | 1.12759 | 14.86 | 1.1188 | 1.13801 | 3 |
FQ4 2025 (Dec 2025) | 1.1173 | -23.51 | 1.10859 | 1.12763 | 5 |
FQ3 2025 (Sep 2025) | 0.93418 | 28.28 | 0.92304 | 0.9533 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.25B | -- | 2.23B | 2.29B | 4 |
FQ3 2027 (Sep 2027) | 2.02B | -- | 2B | 2.06B | 4 |
FQ2 2027 (Jun 2027) | 2.05B | -- | 2.04B | 2.09B | 4 |
FQ1 2027 (Mar 2027) | 2.21B | -- | 2.19B | 2.25B | 4 |
FQ4 2026 (Dec 2026) | 2.19B | -- | 2.18B | 2.21B | 3 |
FQ3 2026 (Sep 2026) | 1.94B | -- | 1.92B | 1.97B | 2 |
FQ2 2026 (Jun 2026) | 1.99B | -- | 1.97B | 2.02B | 2 |
FQ1 2026 (Mar 2026) | 2.14B | 11.39 | 2.13B | 2.16B | 3 |
FQ4 2025 (Dec 2025) | 2.06B | 7.26 | 2.05B | 2.07B | 4 |
FQ3 2025 (Sep 2025) | 1.81B | 4 | 1.79B | 1.84B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.13758 | 0.96 | -0.17758 | -18.5% |
FQ4 2024 (Dec 2024) | 1.01685 | 1.38 | 0.36315 | 26.32% |
FQ3 2024 (Sep 2024) | 0.67 | 0.67 | 100% | |
FQ2 2024 (Jun 2024) | 1.87 | 1.87 | 100% | |
FQ1 2024 (Mar 2024) | 1.06 | 1.06 | 100% | |
FQ4 2023 (Dec 2023) | 1.53 | 1.53 | 100% | |
FQ3 2023 (Sep 2023) | 0.8 | 0.8 | 100% | |
FQ2 2023 (Jun 2023) | 1.9 | 1.9 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $2.01B | $1.9B | $-112.94M | -5.94% |
FQ4 2024 (Dec 2024) | $1.93B | $1.91B | $-22.59M | -1.18% |
FQ3 2024 (Sep 2024) | $0B | $1.74B | $1737.87M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.74B | $1739.64M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.88B | $1876.58M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.87B | $1865.16M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.59B | $1594M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.65B | $1647M | 100% |